Saturday 17 October 2026
Export NAKA’s income statement to Excel — free account
KindlyMD, Inc.
NAKA Financial Capital Markets
KindlyMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 million, down 33.0% from fiscal 2024. In the quarter to June 2026, revenue grew 8,680.7%, EPS grew 52.5% and free cash flow fell 25.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
7.13
0.96
−11.87%
Follow NAKA
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
Piotroski F-Score |
— | — | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 |
P/S ratio |
4.06 | 2.46 | 31.51 |
P/FCF ratio |
0.00 | 0.00 | 0.00 |
P/Operating CF |
(65.32) | (7.42) | (9.29) |
P/B ratio |
0.00 | 2.60 | 0.14 |
Price to Tangible BV |
0.00 | 2.60 | 0.14 |
EV/Sales |
4.02 | 1.63 | 22.07 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
(16.67) | (1.44) | (2.09) |
EV/FCF |
(16.42) | (1.27) | (0.07) |
Quick Ratio |
0.68 | 3.81 | 0.10 |
Current Ratio |
0.76 | 4.13 | 1.04 |
Net Debt/EBITDA |
0.21 | 0.82 | 0.12 |
Debt/Assets |
20.82% | 0.21% | 0.00% |
Debt/Equity |
(2.11) | 0.00 | 0.00 |
Asset Turnover |
0.00 | 1.14 | 0.01 |
Operating CF/Net income |
0.28 | 0.85 | 0.45 |
Capex/Depreciation |
(0.06) | (0.68) | (213.60) |
Interest Coverage |
(29.04) | (8.51) | (27.92) |
| 0.00% | (294.13%) | (20.21%) | |
| 0.00% | (151.45%) | (14.23%) | |
ROIC |
0.00% | (691.95%) | (25.06%) |
Return on Tangible Assets |
(4,279.10%) | (178.86%) | (666.87%) |
Average Days of Receivables |
2.71 | 4.95 | 0.00 |
Research and Development Expense of Revenue |
0.07% | 13.89% | 0.00% |
Selling, General and Administrative Expense of Revenue |
134.12% | 201.10% | 1,254.62% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
21.97% | 8.86% | 129.52% |
Graham Net Nets |
(0.06) | 0.21 | 0.11 |
Graham Number |
17.65 | 0.00 | 0.00 |
Earnings Yield |
(12.54%) | (53.23%) | (247.86%) |
Free Cash Flow Yield |
(6.04%) | (51.98%) | (1,028.19%) |
Revenue per Share |
33.50 | 20.18 | 0.36 |
Operating CF per Share |
(4.00) | (22.80) | (4.70) |
Capex per Share |
(0.13) | (2.98) | (130.92) |
Free Cash Flow per Share |
(4.12) | (25.78) | (135.62) |
Cash per Share |
4.67 | 16.87 | 4.51 |
Shareholders Equity per Share |
(0.96) | 19.05 | 102.75 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
(0.96) | 19.05 | 102.75 |
Free Cash Flow |
(0.46) | (3.48) | (678.77) |
Working Capital |
(0.20) | 1.90 | 7.83 |
Capital Expenditures |
(0.01) | (0.40) | (655.26) |
Net Current Asset Value |
(0.59) | 1.40 | 7.47 |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.15 | 359.77 |
Price to Operating Income |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
0.95 | 4.84 | 0.00 |
Cash ROIC |
(71.81%) | (71.67%) | (126.44%) |
Accounts Receivable Turnover |
0.00 | 83.82 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.25 | 0.00 |
Inventory Turnover |
0.00 | 2.45 | — |
Average Days of Payables |
532.17 | 1,426.94 | 0.00 |
Days of Inventory on Hand |
101.98 | 18.96 | — |
Average Receivables |
— | 0.03 | — |
Average Payables |
— | 0.33 | 3.09 |
Average Inventory |
— | 0.03 | — |
Average Assets |
— | 2.39 | 367.14 |
Average Common Equity |
— | 1.23 | 258.41 |
Columns are period end dates